vs
ConnectOne Bancorp, Inc.（CNOB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
ConnectOne Bancorp, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$115.6M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 32.7%，领先351.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 32.5%）
原公民共和银行控股公司是公民银行的母公司，总部位于密歇根州弗林特市。该公司曾在密歇根、威斯康星和俄亥俄三州运营219家分行与248台自动取款机，2013年6月与第一美德银行合并，第一美德后于2016年被亨廷顿银行控股收购。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CNOB vs RIGL — 直观对比
营收规模更大
CNOB
是对方的1.7倍
$69.8M
净利率更高
RIGL
高出351.3%
32.7%
两年增速更快
RIGL
近两年复合增速
32.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.6M | $69.8M |
| 净利润 | $37.8M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 32.7% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | 86.8% | 1769.2% |
| 每股收益（稀释后） | $0.72 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNOBRIGL
| Q1 26 | $115.6M | — | ||
| Q4 25 | $112.6M | $69.8M | ||
| Q3 25 | $121.4M | $69.5M | ||
| Q2 25 | $84.1M | $101.7M | ||
| Q1 25 | $70.2M | $53.3M | ||
| Q4 24 | $68.5M | $57.6M | ||
| Q3 24 | $65.6M | $55.3M | ||
| Q2 24 | $65.8M | $36.8M |
净利润CNOBRIGL
| Q1 26 | $37.8M | — | ||
| Q4 25 | — | $268.1M | ||
| Q3 25 | $41.0M | $27.9M | ||
| Q2 25 | $-20.3M | $59.6M | ||
| Q1 25 | $20.2M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $17.2M | $12.4M | ||
| Q2 24 | $19.1M | $-1.0M |
毛利率CNOBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率CNOBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 47.4% | 33.2% | ||
| Q3 25 | 47.2% | 40.9% | ||
| Q2 25 | -30.1% | 60.1% | ||
| Q1 25 | 39.0% | 23.9% | ||
| Q4 24 | 38.6% | 28.9% | ||
| Q3 24 | 35.3% | 25.4% | ||
| Q2 24 | 39.1% | 1.2% |
净利率CNOBRIGL
| Q1 26 | 32.7% | — | ||
| Q4 25 | — | 384.0% | ||
| Q3 25 | 33.7% | 40.2% | ||
| Q2 25 | -24.1% | 58.6% | ||
| Q1 25 | 28.8% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 26.2% | 22.5% | ||
| Q2 24 | 28.9% | -2.8% |
每股收益（稀释后）CNOBRIGL
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.88 | $14.11 | ||
| Q3 25 | $0.78 | $1.46 | ||
| Q2 25 | $-0.52 | $3.28 | ||
| Q1 25 | $0.49 | $0.63 | ||
| Q4 24 | $0.48 | $0.82 | ||
| Q3 24 | $0.41 | $0.70 | ||
| Q2 24 | $0.46 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $344.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.6B | $391.5M |
| 总资产 | $14.2B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CNOBRIGL
| Q1 26 | $344.5M | — | ||
| Q4 25 | $380.9M | $155.0M | ||
| Q3 25 | $542.7M | $137.1M | ||
| Q2 25 | $596.5M | $108.4M | ||
| Q1 25 | $292.6M | $77.1M | ||
| Q4 24 | $356.5M | $77.3M | ||
| Q3 24 | $247.2M | $61.1M | ||
| Q2 24 | $293.5M | $49.1M |
总债务CNOBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益CNOBRIGL
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $391.5M | ||
| Q3 25 | $1.5B | $117.6M | ||
| Q2 25 | $1.5B | $81.9M | ||
| Q1 25 | $1.3B | $18.6M | ||
| Q4 24 | $1.2B | $3.3M | ||
| Q3 24 | $1.2B | $-14.6M | ||
| Q2 24 | $1.2B | $-29.9M |
总资产CNOBRIGL
| Q1 26 | $14.2B | — | ||
| Q4 25 | $14.0B | $513.6M | ||
| Q3 25 | $14.0B | $242.5M | ||
| Q2 25 | $13.9B | $206.7M | ||
| Q1 25 | $9.8B | $176.0M | ||
| Q4 24 | $9.9B | $164.0M | ||
| Q3 24 | $9.6B | $139.4M | ||
| Q2 24 | $9.7B | $128.4M |
负债/权益比CNOBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CNOBRIGL
| Q1 26 | — | — | ||
| Q4 25 | $106.4M | $22.0M | ||
| Q3 25 | $37.4M | $24.0M | ||
| Q2 25 | $6.5M | $30.5M | ||
| Q1 25 | $14.9M | $-893.0K | ||
| Q4 24 | $60.7M | $14.5M | ||
| Q3 24 | $-14.4M | $21.7M | ||
| Q2 24 | $22.3M | $302.0K |
自由现金流CNOBRIGL
| Q1 26 | — | — | ||
| Q4 25 | $101.0M | — | ||
| Q3 25 | $33.9M | — | ||
| Q2 25 | $6.4M | — | ||
| Q1 25 | $14.6M | — | ||
| Q4 24 | $56.9M | — | ||
| Q3 24 | $-15.6M | — | ||
| Q2 24 | $22.2M | — |
自由现金流率CNOBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 89.7% | — | ||
| Q3 25 | 27.9% | — | ||
| Q2 25 | 7.6% | — | ||
| Q1 25 | 20.8% | — | ||
| Q4 24 | 83.1% | — | ||
| Q3 24 | -23.8% | — | ||
| Q2 24 | 33.7% | — |
资本支出强度CNOBRIGL
| Q1 26 | — | — | ||
| Q4 25 | 4.8% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 0.2% | — |
现金转化率CNOBRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | 0.91× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | 0.74× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | -0.84× | 1.75× | ||
| Q2 24 | 1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNOB
| Net Interest Income | $108.8M | 94% |
| Noninterest Income | $6.8M | 6% |
RIGL
暂无分部数据
